660. In vitro activity of cefiderocol against difficult-to-treat resistance European Gram-negative bacterial pathogens from the multi-national sentinel surveillance study, SENTRY in 2020 and 2021

BACKGROUND: Difficult-to-treat resistance (DTR) organisms are defined as non-susceptible to all first-line high-efficacy, low-toxicity antibiotics (penicillins, cephalosporins, carbapenems and fluoroquinolones), leaving physicians with limited treatment options. Cefiderocol is a parenteral sideropho...

Descripción completa

Detalles Bibliográficos
Autores principales: Santerre Henriksen, Anne Laurence, Longshaw, Christopher M, Shortridge, Dee, Streit, Jennifer M, Takemura, Miki, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752030/
http://dx.doi.org/10.1093/ofid/ofac492.712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752030/
http://dx.doi.org/10.1093/ofid/ofac492.712

Ejemplares similares